Elevation of metallothionein level in preneoplastic lesions during chemical hepatocarcinogenesis of the Fischer 344 rat

Toxicology Letters

Volumn 108, Issue 1, 1999, Pages 55-61

  Sawaki, Masakuni ^a,b   Enomoto, Katsuhiko ^c   Hattori, Atsuo ^d   Tsuzuki, Naoto ^b   Sawada, Norimasa ^b   Mori, Michio ^b  

^a CHEMICALS EVALUATION AND RESEARCH INSTITUTE   (Japan)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Sapporo Social Insurance General Hospital   (Japan)

Author keywords

Experimental hepatocarcinogenesis; Metallothionein; Preneoplastic lesions

Indexed keywords

BROXURIDINE; DIETHYLNITROSAMINE; GLUTATHIONE TRANSFERASE; METALLOTHIONEIN; N (2 FLUORENYL)ACETAMIDE; TUMOR MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; LIVER CANCER; LIVER CARCINOGENESIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

2-ACETYLAMINOFLUORENE; ANIMALS; DIETHYLNITROSAMINE; GLUTATHIONE TRANSFERASE; LIVER NEOPLASMS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; METALLOTHIONEIN; MUTAGENS; PRECANCEROUS CONDITIONS; RATS; RATS, INBRED F344;

EID: 0033618455     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(99)00127-7     Document Type: Article

References (39)

1. Abdel Mageed A., Agrawal K.C. Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells. Cancer Gene Ther. 4:1997;199-207.
2. Abdel Mageed A.B., Agrawal K.C. Activation of nuclear factor κB: potential role in metallothionein-mediated mitogenic response. Cancer Res. 58:1998;2335-2338.
3. Bahnson R.R., Banner B.F., Ernstoff M.S., Lazo J.S., Cherian M.G., Banerjee D., Chin J.L. Immunohistochemical localization of metallothionein in transitional cell carcinoma of the bladder. J. Urol. 146:1991;1518-1520.
4. Bauman J.W., Liu J., Liu Y.P., Klaassen C.D. Increase in metallothionein produced by chemicals that induce oxidative stress. Toxicol. Appl. Pharmacol. 110:1991;347-354.
5. Cherian M.G. The significance of the nuclear and cytoplasmic localization of metallothionein in human liver and tumor cells. Environ. Health Perspect. 102(Suppl. 3):1994;131-135.
6. Cherian M.G., Howell S.B., Imura N., Klaassen C.D., Koropatnick J., Lazo J.S., Waalkes M.P. Contemporary issues in toxicology: Role of metallothionein in carcinogenesis. Toxicol. Appl. Pharmacol. 126:1994;1-5.
7. Chin J.L., Banerjee D., Kadhim S.A., Kontozoglou T.E., Chauvin P.J., Cherian M.G. Metallothionein in testicular germ cell tumors and drug resistance: Clinical correlation. Cancer. 72:1993;3029-3035.
8. Enomoto K., Takahashi H., Mori M. A new rat model for the study of hepatocarcinogenesis. J. Gastroenterol. Hepatol. 7:1992;98-104.
9. Giuffrè G., Barresi G., Sturniolo G.C., Sarnelli R., Dincà R., Tuccari G. Immunohistochemical expression of metallothionein in normal human colorectal mucosa, in adenomas and in adenocarcinomas and their associated metastases. Histopathology. 29:1996;347-354.
10. Hashimoto Y., Tajima O., Hashiba H., Nose K., Kuroki T. Elevated expression of secondary, but not early, responding genes to phorbol ester tumor promoters in papillomas and carcinomas of mouse skin. Mol. Carcinog. 3:1990;302-308.
11. Kondo Y., Rusnak J.M., Hoyt D.G., Settineri C.E., Pitt B.R., Lazo J.S. Enhanced apoptosis in metallothionein null cells. Mol. Pharmacol. 52:1997;195-201.
12. Kuo T., Lo S.K. Immunohistochemical metallothionein expression in thymoma: correlation with histological types and cellular origin. Histopathology. 30:1997;243-248.
13. Lee G-H. Correlation between bcl-2 expression and histopathology in diethylnitrosamine-induced mouse hepatocellular tumors. Am. J. Pathol. 151:1997;957-961.
14. Liu J., Liu Y., Habeebu S.S., Klaassen C.D. Metallothionein (MT)-null mice are sensitive to cisplatin-induced hepatotoxicity. Toxicol. Appl. Pharmacol. 149:1998;24-31.
15. Monden N., Abe S., Sutoh I., Hishikawa Y., Kinugasa S., Nagasue N. Prognostic significance of the expressions of metallothionein, glutathione-S-transferase-pi, and P-glycoprotein in curatively resected gastric cancer. Oncology. 54:1997;391-399.
16. Mori, M., Yoshida, M.C., Takeichi, N., Taniguchi, N., 1991. The LEC rat. A new model for hepatitis and liver cancer. Springer-Verlag Tokyo, Tokyo.
17. Nakajima K., Suzuki K., Otaki N., Kimura M. Epitope mapping of metallothionein antibodies. Methods Enzymol. 205:1991;174-189.
18. Nakajima K., Suzuki K., Otaki N., Kimura M. Detection of metallothionein in brain. Method Enzymol. 205:1991;387-395.
19. Nartey N., Cherian M.G., Banerjee D. Immunohistochemical localization of metallothionein in human thyroid tumors. Am. J. Pathol. 129:1987;177-182.
20. Nishimura H., Nishimura N., Tohyama C. Immunohistochemical localization of metallothionein in developing rat tissues. J. Histochem. Cytochem. 37:1989;715-722.
21. Oberdörster G., Cherian M.G., Baggs R.B. Importance of species differences in experimental pulmonary carcinogenicity of inhaled cadmium for extrapolation to humans. Toxicol. Lett. 72:1994;339-343.
22. Ohshio G., Imamura T., Okada N., Wang Z.H., Yamaki K., Kyogoku T., Suwa H., Yamabe H., Imamura M. Immunohistochemical study of metallothionein in pancreatic carcinomas. J. Cancer Res. Clin. Oncol. 122:1996;351-355.
23. Oyama T., Take H., Hikino T., Iino Y., Nakajima T. Immunohistochemical expression of metallothionein in invasive breast cancer in relation to proliferative activity, histology and prognosis. Oncology. 53:1996;112-117.
24. Sato M., Bremmer I. Oxygen free radicals and metallothionein. Free Radic. Biol. Med. 14:1993;325-337.
25. Satoh M., Kondo Y., Mita M., Nakagawa I., Naganuma A., Imura N. Prevention of carcinogenicity of anticancer drugs by metallothionein induction. Cancer Res. 53:1993a;4767-4768.
26. Satoh M., Kloth D.M., Kadhim S.A., Chin J.L., Naganuma A., Imura N., Cherian M.G. Modulation of both cisplatin nephrotoxicity and drug resistance in murine bladder tumor by controlling metallothionein synthesis. Cancer Res. 53:1993b;1829-1832.
27. Sawaki M., Enomoto K., Hattori A., Tsuzuki N., Sugawara N., Mori M. Role of copper accumulation and metallothionein induction for the spontaneous liver cancer development in LEC rats. Carcinogenesis. 15:1994;1833-1837.
28. Schwalz M.A., Lazo J.S., Yalowich J.C., Reynolds I., Kagan V.E., Tyurin V., Kim Y., Watkins S.C., Pitt B.R. Cytoplasmic metallothionein overexpression protects NIH3T3 cells from tert-butyl hydroperoxide toxicity. J. Biol. Chem. 269:1994;15238-15243.
29. Takeda A., Hisada H., Okada S., Mata J.E., Ebadi M., Iversen P.L. Tumor cell growth is inhibited by suppressing metallothionein-I synthesis. Cancer Lett. 116:1997;145-149.
30. Takeichi N., Kobayashi H., Yoshida M.C., Sasaki M., Dempo K., Mori M. Spontaneous hepatitis in Long-Evans rats. Acta Pathol. Jpn. 38:1988;1369-1375.
31. Thornalley P.J., Väsák M. Possible role for metallothionein in protection against radiation-induced oxidative stress. Kinetics and mechanism of its reaction with superoxide and hydroxyl radicals. Biochim. Biophys. Acta. 827:1985;36-44.
32. Tsuchida S., Sato K. Glutathione transferases and cancer. Crit. Rev. Biochem. Mol. Biol. 27:1992;337-384.
33. Tsujikawa K., Imai T., Kakutani M., Kayamori Y., Mimura T., Otaki N., Kimura M., Fukuyama R., Shimizu N. Localization of metallothionein in nuclei of growing primary cultured adult rat hepatocytes. FEBS Lett. 283:1991;239-242.
34. Yoshida L.S., Miyazawa T., Hatayama I., Sato K., Fujimoto K., Kaneda T. Phosphatidylcholine peroxidation and liver cancer in mice fed a choline-deficient diet with ethionine. Free Radic. Biol. Med. 14:1993;191-199.
35. Waalkes M.P., Diwan B.A., Rehm S., Ward J.M., Moussa M., Cherian M.G., Goyer R.A. Down-regulation of metallothionein expression in human and murine hepatocellular tumors: association with the tumor-necrotizing and antineoplastic effects of cadmium in mice. J. Pharmacol. Exp. Ther. 277:1996;1026-1033.
36. waf1/cip1 is induced in the rat liver by feeding of 2-acetylaminofluorene. J. Toxicol. Pathol. 11:1998;191-196.
37. Wirth P.J., Rao M.S., Evarts R.P. Coordinate polypeptide expression during hepatocarcinogenesis in male F-344 rats: comparison of the Solt-Farber and Reddy models. Cancer Res. 47:1987;2839-2851.
38. Zhang X.H., Jin L., Sakamoto H., Takenaka I. Immunohistochemical localization of metallothionein in human prostate cancer. J. Urol. 156:1996a;1679-1681.
39. Zhang X.H., Jin L., Takenaka I. Localization of zinc and metallothionein in the rat bladder epithelium during carcinogenesis induced by N-butyl-N-(4-hydroxybutyl) nitrosamine. Urol. Res. 24:1996b;279-283.